Consensus Moderna, Inc. Deutsche Boerse AG

Stocks

0QF

US60770K1079

Pharmaceuticals

Market Closed - Deutsche Boerse AG 14:24:01 2026-09-30 EDT			5-day change	1st Jan Change
168.82 ^EUR	-6.22%		+5.55%	+534.07%

09-30	Moderna, Inc. Announces Management Changes	CI
09-30	S&P 500 dips, Nasdaq higher after data shows moderate inflation rise	RE

fb90bd99.hwxFenPLZL4HYnF2wvE0YD_71IGz1awdu18yDgeUU_I.xkAUAAeuFPo0B1xb8cAZP1OckeDE7PhewydgT03DAMLldSJPIL4lyjIbNA~58412b391ae9143b6dfc4b75ded022b7

Analysts' recommendations: Moderna, Inc.

09-30	Citigroup Downgrades Moderna to Sell From Neutral, Adjusts Price Target to $80 From $60	MT
09-11	Berenberg Boosts Price Target on Moderna to $100 From $45, Keeps Hold Rating	MT
09-09	Moderna Set for 3 Near-Term INT Data Readouts, UBS Says	MT
09-03	Evercore ISI Adjusts Moderna Price Target to $80 From $50, Maintains In Line Rating	MT
09-03	Wall Street's Triple Squeeze
09-03	Rothschild & Co Redburn Downgrades Moderna to Sell From Neutral, Adjusts PT to $81 From $40	MT
09-03	Analyst recommendations: Copart, Moderna, Broadcom, DuPont de Nemours…
08-28	Argus Research Upgrades Moderna to Buy From Hold, $180 Price Target	MT
08-26	U.S. research roundup- Intuit, MongoDB, Zscaler	RE
08-26	Deutsche Bank Adjusts Moderna Price Target to $125 From $45, Maintains Hold Rating	MT
08-25	Moderna Shares Rise After Wolfe Research Upgrade	MT
08-25	Wolfe Upgrades Moderna to Peer Perform From Underperform	MT
08-24	Barclays Adjusts Price Target on Moderna to $125 From $48	MT
08-24	Analyst recommendations: Kimberly-Clark, Palantir, Snap, Crowdstrike, Accenture…
08-21	JPMorgan Adjusts Price Target on Moderna to $77 From $40, Keeps Underweight Rating	MT
08-21	Analyst recommendations: Equifax, Medpace Holdings, Applied Materials, PayPal, Moderna…
08-20	UBS Adjusts Moderna Price Target to $150 From $50, Maintains Neutral Rating	MT
08-20	Jefferies Adjusts Price Target on Moderna to $150 From $60, Keeps Hold Rating	MT
08-20	Piper Sandler Adjusts Price Target on Moderna to $167 From $77, Keeps Overweight Rating	MT
08-20	Analyst recommendations: Datadog, Merck, Estee Lauder, Moderna, Target…
08-19	Piper Sandler Adjusts Price Target on Moderna to $167 From $77, Maintains Overweight Rating	MT
08-19	BofA Securities Upgrades Moderna to Neutral From Underperform Following Intismeran 'Success', Raises Price Target to $170 From $40	MT
08-19	Goldman Sachs Adjusts Price Target on Moderna to $120 From $67, Keeps Neutral Rating	MT
08-19	Moderna and Merck & Co, the day's Wall Street standouts
08-19	William Blair Upgrades Moderna to Outperform From Market Perform	MT

More recommendations

Biopharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ELI LILLY AND COMPANY					+12.17%
	JOHNSON & JOHNSON					+4.37%
	ABBVIE INC.					+5.91%
	MERCK & CO., INC.					+4.29%
	ROCHE HOLDING AG					+7.46%
	NOVARTIS AG					+5.11%
	ASTRAZENECA PLC					+28.35%
	AMGEN INC.					-7.72%
	GILEAD SCIENCES, INC.					+4.87%
	Average					+7.20%
	Weighted average by Cap.					+7.93%